0001415889-12-001519.txt : 20121022 0001415889-12-001519.hdr.sgml : 20121022 20121022121714 ACCESSION NUMBER: 0001415889-12-001519 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120808 FILED AS OF DATE: 20121022 DATE AS OF CHANGE: 20121022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILSON JOHN S CENTRAL INDEX KEY: 0001497703 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52369 FILM NUMBER: 121154154 MAIL ADDRESS: STREET 1: 11011 Q STREET STREET 2: BUILDING A, SUITE 106 CITY: OMAHA STATE: NE ZIP: 68137 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOND LABORATORIES, INC. CENTRAL INDEX KEY: 0001374328 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11011 Q STREET BUILDING A STREET 2: SUITE 106 CITY: OMAHA STATE: NE ZIP: 68137 BUSINESS PHONE: 402-884-1894 MAIL ADDRESS: STREET 1: 11011 Q STREET BUILDING A STREET 2: SUITE 106 CITY: OMAHA STATE: NE ZIP: 68137 4 1 form4-10222012_091004.xml X0306 4 2012-08-08 0001374328 BOND LABORATORIES, INC. BNLB.OB 0001497703 WILSON JOHN S 4509 S. 143RD STREET SUITE 1 OMAHA NE 68137 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2012-08-08 4 J 0 120000 0.045 A 1249654 D Stock Option 0.10 2011-06-08 2021-06-08 Common Stock 500000 500000 D Warrant 0.15 2008-12-31 2013-12-31 Common Stock 1000000 1000000 D Stock Option 0.09 2012-05-09 2017-04-13 Common Stock 500000 500000 D Series C Convertible Preferred Stock 0.25 Common Stock 668000 16.7 D Warrant 0.30 2015-11-15 Common Stock 332500 332500 D Mr. Wilson acquired the shares in a privately negotiated transaction in connection with the settlement of litigation. The Series C Preferred and the Warrant were issued on September 17, 2012 and were immediately convertible, or exercisable, as the case may be. The Series C Preferred are perpetual. Each Series C Preferred converts on a 1-for-40,000 basis. /s/ John S. Wilson 2012-10-22